Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer Genmab A/S announced today new datademonstrating thatrinatabart sesutecan (Rina-S®), an investigational folate receptor alpha (FRα)-targeted, topoisomerase I (TOPO1)-inhibitor antibody-drug conjugate (ADC), evaluated in…
Study Finds Biofield Therapy Slows Pancreatic Cancer Progression and Reduces Metastasis Biofield therapy (BT)—a non-invasive, practitioner-administered therapy—can significantly slow the growth and spread of pancreatic cancer in pre-clinical models, according to a new study led by researchers at The University…
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral…
Covalon Technologies Ltd. Highlights Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting Covalon Technologies Ltd., a company specializing in advanced medical technologies for wound care and infection prevention, has announced its participation in the Infusion…
Ossium Health Welcomes Indiana Governor Mike Braun and Healthcare Leaders for Facility Tour and Reception Ossium Health recently opened its doors to state officials, healthcare leaders, and members of the regional life sciences community for a special facility tour and…
A Significant Proportion of Adults in the Community May Be Unaware They Are Living with Prediabetes The El Camino Healthcare District has launched a comprehensive new initiative aimed at tackling one of the most widespread yet underrecognized health concerns in…
Fresenius Kabi Receives CMS Approval for COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg) Fresenius Kabi, a subsidiary of Fresenius and a global leader in essential medicines and medical technologies, has announced a significant reimbursement milestone for its biologic therapy Tyenne®…
Assertio Enters Definitive Agreement for Acquisition by Garda Therapeutics Assertio Holdings Inc. has announced a transformative set of transactions that will significantly reshape the company’s structure and deliver immediate value to shareholders. The company revealed that it has entered into…
Pilatus Biosciences to Showcase New Data on Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 Pilatus Biosciences has announced that it will present new preclinical findings at the upcoming AACR Annual Meeting 2026, scheduled to take place…
Shionogi & Co., Ltd. Secures U.S. Government Contract via BARDA Project BioShield to Strengthen Preparedness Against Drug-Resistant Bacterial Threats Shionogi & Co., Ltd. has announced that its U.S.-based subsidiary, Shionogi Inc., has been awarded a significant federal contract under Biomedical…
United Therapeutics Corporation Receives U.S. Food and Drug Administration Regenerative Medicine Advanced Therapy (RMAT) Designation for miroliverELAP® in the Treatment of Acute Liver Failure United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation focused on developing innovative therapies for end-stage…
VION Biosciences Completes Acquisition of CTL, Bolstering Its Functional Immune Monitoring Capabilities VION Biosciences (“VION”), a life sciences company focused on building differentiated capabilities across research, diagnostics, and drug development workflows, has announced the successful completion of its acquisition of…